Journal
Cell Death & Disease
Publication Date
2018
Volume
9
Document Type
Open Access Publication
Rights and Permissions
Redlich, N., Robinson, A. M., Nickel, K. P., Stein, A. P., Wheeler, D. L., Adkins, D. R., . . . Michel, L. S. (2018). Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma. Cell Death and Disease, 9(1)10.1038/s41419-017-0029-0 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any mediumor format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changesweremade. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Copyright 2018 The Author(s)
Recommended Citation
Redlich, Nathan; Robinson, Anthony M.; Nickel, Kwangok P.; Stein, Andrew P.; Wheeler, Deric L.; Adkins, Douglas R.; Uppaluri, Ravindra; Kimple, Randall J.; Van Tine, Brian A.; and Michel, Loren S., "Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma." Cell Death & Disease. 9, (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6550
Supplemental Figure 1.png (23604 kB)
Supplemental Figure 2.png (209 kB)
Supplemental Figure 3.png (22145 kB)
Supplemental Figure 4.png (3433 kB)
Supplemental Figure 5.png (19319 kB)
Supplemental Figure 6.png (3648 kB)
Supplemental Figure 7.png (20514 kB)
Supplemental Figure 8.png (405 kB)
Supplemental Figure 9.png (19550 kB)
